ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
132 hedge funds and large institutions have $803M invested in Alder Biopharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 62 increasing their positions, 24 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
3% more funds holding
Funds holding: 128 → 132 (+4)
22% less call options, than puts
Call options by funds: $1.86M | Put options by funds: $2.39M
Holders
132
Holding in Top 10
4
Calls
$1.86M
Puts
$2.39M
Top Buyers
| 1 | +$52.1M | |
| 2 | +$21.5M | |
| 3 | +$17.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$16.1M |
| 5 |
PA
Pinnacle Associates
New York
|
+$14.8M |
Top Sellers
| 1 | -$26.7M | |
| 2 | -$17.3M | |
| 3 | -$16.2M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.55M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$5.36M |